| BSPAX | VSMPX | BSPAX / VSMPX | |
| Total Expense Ratio | 0.35 | 0.02 | 1,750% |
| Annual Report Gross Expense Ratio | 0.35 | 0.02 | 1,750% |
| Fund Existence | 13 years | 11 years | - |
| Gain YTD | 12.566 | 12.876 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 60.3B | 2.29T | 3% |
| Annual Yield % from dividends | 0.76 | 1.07 | 71% |
| Returns for 1 year | 20.64 | 21.03 | 98% |
| Returns for 3 years | 78.34 | 74.33 | 105% |
| Returns for 5 years | 78.96 | 66.62 | 119% |
| Returns for 10 years | 285.09 | 238.83 | 119% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCILX | 22.19 | 0.25 | +1.14% |
| BlackRock International Inv C | |||
| PHPIX | 49.35 | 0.45 | +0.92% |
| ProFunds Pharmaceuticals UltraSector Inv | |||
| TRZDX | 91.29 | 0.53 | +0.58% |
| T. Rowe Price Dividend Growth Z | |||
| PSCJX | 28.12 | 0.16 | +0.57% |
| PGIM Jennison Small Company R4 | |||
| ETAMX | 15.29 | -0.02 | -0.13% |
| Eventide Balanced Fund Class A | |||